A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Idelalisib and Rituximab for Previously Treated Patients with Chronic Lymphocytic Leukemia (CLL)
暂无分享，去创建一个
A. Zelenetz | I. Flinn | B. Coiffier | A. Pettitt | B. Cheson | T. Kipps | M. Hallek | S. Stilgenbauer | S. O'brien | T. Jahn | J. Pagel | L. Miller | S. Coutre | P. Ghia | T. Ervin | P. Cramer | J. Sharman | P. Hillmen | H. Eradat | N. Lamanna | J. Barrientos | D. Johnson | R. Dansey | Daniel Li | Maria Aiello | Shuo Ma